# Ningbo Medicalsystem Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ningbo-medicalsystem-biotechnology-co

- Industry: Medical Devices & Equipment
- Headquarters: Ningbo, China
- Website: www.nbmksw.com
- Total disclosed funding: $1.6M
- Latest round: Series A (Nov 30, 2011)
- Investors on record: 1

## About

Founded in 2003 and based in Ningbo, China, Ningbo Medicalsystem Biotechnology Co., Ltd operates as a medical equipment manufacturing company that focuses on the production and sales of in vitro diagnostic reagents and equipment. Bingde Zou, the chairman of the board, graduated from the University of Canberra and was formerly a member of the Ningbo Medical Association. It was recognized as the National High-tech Enterprise. In November 2011, the company raised a series A funding for CNY 10.5 million. In April 2015, the company was listed on the Shenzhen Stock Exchange.

The company is mainly engaged in the research and development of in vitro diagnostic reagents and instruments and independent third-party medical diagnostic services. Its product line covers biochemistry, luminescence, blood cells, urine, and other series. Products include MS-L8080 biochemical analyzers, MS-i3080 chemiluminescence immunoassay analyzers, Altis Plus triple quadrupole mass spectrometers, various test kits, etc. The MS-L8080 biochemical analyzer can load 410 samples at a time and can detect glycated hemoglobin in whole blood.

The company generates revenue by providing in vitro diagnostic reagents and instruments, as well as medical diagnostic services.

## Funding rounds

- Series A, Nov 30, 2011, $1.6M — ABC Capital

## Investors

- ABC Capital (https://capitalatlas.ai/funds/abc-capital) — Series A